BMJ Open Respiratory Research (Dec 2023)

Association of sleep disorders with asthma: a meta-analysis

  • Xiang Ren,
  • Lihua Fan,
  • Zhiyu Liu,
  • Xueqian Liu,
  • Cheng Hong,
  • Moqing Yin,
  • Yunhu Chen,
  • Xuefang Gu

DOI
https://doi.org/10.1136/bmjresp-2023-001661
Journal volume & issue
Vol. 10, no. 1

Abstract

Read online

Background Animal experiments and clinical trials have revealed a potential relationship between sleep disorders and asthma. However, the associations between these factors remain unclear.Material and methods We searched PubMed, Embase, Web of Science and Cochrane Library databases for eligible studies published before 30 December 2022. Studies investigating the association between sleep disorders (insomnia, poor sleep quality and insufficient sleep time) and asthma were selected. Sleep disorders were assessed using questionnaires, interviews, or medical records. Asthma was diagnosed based on medical history and drug use. The Newcastle-Ottawa Scale and the Agency for Healthcare Research and Quality checklist were employed for quality assessment. We used OR with 95% CI as the effect measures and forest plots to display the results. Heterogeneity was evaluated using I2 statistics and subgroup analyses were performed for bias analysis. Publication bias was evaluated using the funnel plots and Egger’s test.Results Twenty-three studies were included in the primary analysis, which suggested a positive association between sleep disorders and asthma (OR: 1.38, 95% CI 1.10 to 1.74). Subgroup analyses were conducted according to the study design, age, family history of asthma and type of sleep disorders. We did not find any association between sleep disorders and asthma in children aged ˂12 years (OR: 1.13, 95% CI 0.97 to 1.32). The association was insignificant in studies where the family history of asthma was adjusted for (OR: 1.16, 95% CI 0.94 to 1.42). Funnel plot and Egger’s test indicated a significant publication bias.Conclusion Sleep disorders are associated with an increased prevalence and incidence of asthma. However, the quality of the evidence was low because of potential biases.PROSPERO registration number CRD42023391989.